A Georgia House committee advanced a bill denying state health plan coverage for gender-affirming care. The bill would also ban state healthcare facilities and physicians from providing such care.

Gilead Sciences (GILD) (Health Care, Biotechnology) climbed after the biopharmaceutical company posted stronger-than-expected quarterly earnings and boosted its full-year outlook. Atlassian (TEAM ...

Split ends are to hair what acne is to skin — a frustrating beauty dilemma that can be stubborn to fix. Many hair care formulas on the market claim to “zip up” or seal split ends, but is this actually ...

powered by two biotech-derived peptides and retailing for $40 for a 50-ml. tube. More from WWD EXCLUSIVE: Ashley Graham Debuts as the Face of New Revlon ColorSilk, Talks Hair Care and Upcoming ...

The ever-buzzy world of hair repair has a new player — albeit ... Goddess Maintenance Co debuts with a BioTech Blowout Leave-in Restorative Mask, powered by two biotech-derived peptides and ...

BEND, Ore. (KTVZ) -- A new analysis conducted for the city of Bend shows planning for growth in sectors like health care and biotech-related fields will be critical in supporting Bend’s economy ...

Castor oil, enriched with essential fatty acids, vitamins, and minerals, is gaining popularity for its potential to promote hair regrowth on bald spots. Regular application of cold-pressed ...

While you are at it, why not refresh your hair? A haircut is among the quickest — and most drastic — changes in appearance that someone can make. No wonder they can induce so much anxiety.

Remember Me Senior Care, a Cleveland-based assisted living and memory care company, has filed for Chapter 11 bankruptcy protection due to alleged financial misdeeds by one of its co-founders, ...

I just came, travelled here from China, where we just introduced it a few months ago. Our goal is to reach all people who need obesity care today, that's almost a billion people, and we're far from ...

There remains much uncertainty about these measures, however. As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative news.